US 11826322
Pre-filled syringe
granted A61KA61K31/137A61K47/02
Quick answer
US patent 11826322 (Pre-filled syringe) held by Teva Pharmaceuticals USA, Inc. expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceuticals USA, Inc.
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/137, A61K47/02, A61K47/12, A61K9/0019